Explore the development of a novel targeted NGS panel for analyzing DNA methylation biomarkers in lung cancer in this 49-minute webinar presented by Dr. Lucia Anna Muscarella, Ph.D. and Dr. Cristina Guillén, Ph.D. Delve into the potential of epigenetic modifications, particularly DNA methylation, as promising biomarkers for diagnosing and guiding treatment of various human diseases, including multiple cancer types. Understand the technical limitations that have hindered widespread clinical adoption of DNA methylation biomarkers and discover how this innovative approach aims to overcome these challenges. Gain insights into the latest advancements in epigenetic research and its implications for lung cancer diagnosis and treatment.
Development of a Novel Targeted NGS Panel for Analysis of DNA Methylation Biomarkers in Lung Cancer
Overview
Syllabus
Development of a Novel Targeted NGS Panel for Analysis of DNA Methylation Biomarkers in Lung Cancer
Taught by
Labroots
Related Courses
-
Constitutional DNA Methylation Testing in the Clinical Setting
-
Utilization of the Genexus Turnkey NGS Platform for Molecular Profiling of NSCLC Samples
-
Epigenetic Aging Studies in Mammals - Universal DNA Methylation Clocks and Lifespan
-
Overcome Challenges in Cancer Research with xGen NGS Solutions for Oncology and MRD Research
-
Epigenetic Reprogramming of Brain Development Pathways During Non-Small Cell Lung Cancer Metastasis
-
Measuring Cancer and Immune Systems Using Cell-free DNA Sequencing
